首页 > 市场调查报告书 > 製药

眼科药物

市场调查报告书

商品编码

1386266

遗传性视网膜疾病市场报告：2030 年趋势、预测与竞争分析

Inherited Retinal Disease Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月03日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

遗传性视网膜疾病的趋势与预测

2030年，全球遗传性视网膜疾病市场预计将达到55亿美元，2024年至2030年的年复合成长率为7.5%。该市场的主要驱动因素是政府对 IRD 研究和新治疗方法开发的资助增加、IRD 盛行率上升以及人们对 IRD 的认识不断提高。全球遗传性视网膜疾病 (IRD) 市场的未来看起来充满希望，医院、专科诊所、门诊手术中心和居家医疗市场都充满机会。

遗传性视网膜疾病市场洞察

Lucintel 预测，由于对遗传性视网膜疾病早期诊断的需求不断增加，诊断预计将在预测期内实现强劲增长。

由于医院拥有资源和专业知识，可以为遗传性视网膜疾病患者提供诊断、治疗和復健等广泛的服务，因此医院将继续成为该市场的最大细分市场。

由于其发达的医疗基础设施，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球遗传性视网膜疾病市场趋势（2018-2023）与预测（2024-2030）
按类型分類的全球遗传性视网膜疾病市场
- 诊断
- 治疗
按疾病类型分類的全球遗传性视网膜疾病市场
- 色素性视网膜炎
- 斯塔加特病
- 色盲
- 锥桿营养不良
- 脉络膜血症
- 肝臟先天性黑蒙
- 黄斑部水肿
- 其他的
以最终用途分類的全球遗传性视网膜疾病市场
- 医院
- 专科诊所
- 门诊手术中心
- 家庭保健
- 其他的
按配销通路分類的全球遗传性视网膜疾病市场
- 零售
- 直接竞标

第4章2018-2030年分地区市场趋势及预测分析

全球遗传性视网膜疾病市场（按地区）
北美遗传性视网膜疾病市场
欧洲遗传性视网膜疾病市场
亚太地区遗传性视网膜疾病市场
其他区域遗传性视网膜疾病市场

第5章竞争分析

产品系列分析
营运整合
波特五力分析

第6章成长机会与策略分析

成长机会分析
- 按类型分類的全球遗传性视网膜疾病市场成长机会
- 按疾病类型分類的全球遗传性视网膜疾病市场成长机会
- 全球遗传性视网膜疾病市场成长机会（依最终用途）
- 全球遗传性视网膜疾病市场成长机会（按配销通路）
- 全球遗传性视网膜疾病市场成长机会（按地区）
全球遗传性视网膜疾病市场的新趋势
战略分析
- 新产品开发
- 全球遗传性视网膜疾病市场的产能扩张
- 全球遗传性视网膜疾病市场的合併、收购与合资企业
- 认证和许可

第7章主要企业概况

Spark Therapeutics
Novartis
Okuvision
Nidek
Invitae Corporation
Zeiss
Optos

简介目录

Inherited Retinal Disease Trends and Forecast

The future of the global inherited retinal disease (IRD) market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets. The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030 with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

A more than 150-page report is developed to help in your business decisions.

Inherited Retinal Disease by Segment

The study includes a forecast for the global inherited retinal disease by type, disease type, end use, distribution channel, and region.

Inherited Retinal Disease Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Diagnosis
Therapy

Inherited Retinal Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

Retinitis Pigmentosa
Stargardt'S Disease
Achromatopsia
Cone-Rod Dystrophy
Choroideremia
Leber Congenital Amaurosis
Macular Edema
Others

Inherited Retinal Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Home Healthcare
Others

Inherited Retinal Disease Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

Retail Sales
Direct Tender

Inherited Retinal Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Inherited Retinal Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inherited retinal disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inherited retinal disease companies profiled in this report include-

Spark Therapeutics
Novartis
Okuvision
Nidek
Invitae Corporation
Zeiss
Optos

Inherited Retinal Disease Market Insights

Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Within this market, hospital will remain the largest segment due to the presence of resources and expertise to provide a wide range of services for patients with inherited retinal diseases, including diagnosis, treatment, and rehabilitation.

North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Features of the Global Inherited Retinal Disease Market

Market Size Estimates: Inherited retinal disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inherited retinal disease market size by various segments, such as by type, disease type, end use, distribution channel, and region in terms of ($B).

Regional Analysis: Inherited retinal disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, disease types, end uses, distribution channels, and regions for the inherited retinal disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inherited retinal disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the inherited retinal disease market size?

Answer: The global inherited retinal disease market is expected to reach an estimated $5.5 billion by 2030.

Q.2 What is the growth forecast for inherited retinal disease market?

Answer: The global inherited retinal disease market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the inherited retinal disease market?

Answer: The major drivers for this market are government's increasing funding for research into IRDs and the development of new treatments, rising prevalence of IRDs, and growing awareness of IRD among people.

Q4. What are the major segments for inherited retinal disease market?

Answer: The future of the inherited retinal disease market looks promising with opportunities in the hospital, specialty clinic, ambulatory surgical center, and home healthcare markets.

Q5. Who are the key inherited retinal disease market companies?

Answer: Some of the key inherited retinal disease companies are as follows:

Spark Therapeutics
Novartis
Okuvision
Nidek
Invitae Corporation
Zeiss
Optos

Q6. Which inherited retinal disease market segment will be the largest in future?

Answer: Lucintel forecasts that diagnosis is expected to witness higher growth over the forecast period due to growing demand for early diagnosis of inherited retinal diseases.

Q7. In inherited retinal disease market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to well-developed healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the inherited retinal disease market by type (diagnosis and therapy), disease type (retinitis pigmentosa, stargardt's disease, achromatopsia, cone-rod dystrophy, choroideremia, leber congenital amaurosis, macular edema, and others), end use (hospitals, specialty clinics, ambulatory surgical centers, home healthcare, and others), distribution channel (retail sales and direct tender), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Inherited Retinal Disease Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Inherited Retinal Disease Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Inherited Retinal Disease Market by Type
- 3.3.1: Diagnosis
- 3.3.2: Therapy
3.4: Global Inherited Retinal Disease Market by Disease Type
- 3.4.1: Retinitis Pigmentosa
- 3.4.2: Stargardt's Disease
- 3.4.3: Achromatopsia
- 3.4.4: Cone-Rod Dystrophy
- 3.4.5: Choroideremia
- 3.4.6: Leber Congenital Amaurosis
- 3.4.7: Macular Edema
- 3.4.8: Others
3.5: Global Inherited Retinal Disease Market by End Use
- 3.5.1: Hospitals
- 3.5.2: Specialty Clinics
- 3.5.3: Ambulatory Surgical Centers
- 3.5.4: Home Healthcare
- 3.5.5: Others
3.6: Global Inherited Retinal Disease Market by Distribution Channel
- 3.6.1: Retail Sales
- 3.6.2: Direct Tender

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Inherited Retinal Disease Market by Region
4.2: North American Inherited Retinal Disease Market
- 4.2.2: North American Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.3: European Inherited Retinal Disease Market
- 4.3.1: European Inherited Retinal Disease Market by Type: Diagnosis and Therapy
- 4.3.2: European Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.4: APAC Inherited Retinal Disease Market
- 4.4.1: APAC Inherited Retinal Disease Market by Type: Diagnosis and Therapy
- 4.4.2: APAC Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others
4.5: ROW Inherited Retinal Disease Market
- 4.5.1: ROW Inherited Retinal Disease Market by Type: Diagnosis and Therapy
- 4.5.2: ROW Inherited Retinal Disease Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Inherited Retinal Disease Market by Type
- 6.1.2: Growth Opportunities for the Global Inherited Retinal Disease Market by Disease Type
- 6.1.3: Growth Opportunities for the Global Inherited Retinal Disease Market by End Use
- 6.1.4: Growth Opportunities for the Global Inherited Retinal Disease Market by Distribution Channel
- 6.1.5: Growth Opportunities for the Global Inherited Retinal Disease Market by Region
6.2: Emerging Trends in the Global Inherited Retinal Disease Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Inherited Retinal Disease Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inherited Retinal Disease Market
- 6.3.4: Certification and Licensing